JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Pressing regulatory challenges for psychedelic medicine

Amy L. Mcguire, Holly Fernandez Lynch, Lewis A. Grossman, I. Glenn Cohen

Science April 27, 2023 DOI: 10.1126/science.adg1324 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	Peer reviewed
Keywords	Traditional medicine
Citations	20
Key points	Policy must support generation of evidence on safety and effectiveness.

Abstract

Policy must support generation of evidence on safety and effectiveness.

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines Neuropharmacology August 13, 2022 49 citations
Addressing US Demand for Psychedelic Medicines in the Face of Scientific Uncertainty. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2026 2 citations
Taking Psychedelics Seriously Journal of Palliative Medicine January 22, 2018 164 citations
Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis? Addiction June 6, 2024 18 citations
Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of Psychedelics. ACS Pharmacology & Translational Science August 8, 2025 1 citation